Pressure BioSciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Pressure BioSciences generated cash of -$3,186,010, which is more than the previous year. Cash used in financing activities reached the amount of $3,270,919 last year. Net change in cash is therefore $77,414.
Cash Flow
| 2014 | -3.21M | -7.13K | 3.66M |
|---|---|---|---|
| 2015 | -3.81M | -9.41K | 3.47M |
| 2016 | -3.80M | -7.20K | 3.83M |
| 2017 | -3.90M | -171.82K | 4.01M |
| 2018 | -5.69M | 0 | 5.71M |
| 2019 | -6.32M | -23.37K | 6.27M |
| 2020 | -4.88M | -796.66K | 5.66M |
| 2021 | -4.86M | -122.94K | 5.10M |
| 2022 | -4.47M | -20.75K | 4.37M |
| 2023 | -3.18M | -7.49K | 3.27M |
PBIO Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 3.86K | 132.31K | 18.54K | 29.62K | 103.11K | 81.03K | 138.36K | 116.78K | 473.94K | 31.41K |
Operating activities | ||||||||||
Net income | -29.31M | -16.07M | -20.15M | -16.00M | -11.66M | -9.69M | -10.71M | -2.70M | -7.41M | -4.61M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 112.45K | 119.78K | 110.12K | 127.30K | 123.59K | 94.27K | 8.57K | 17.93K | 25.28K | 65.71K |
Stock-based compensation expense | 6.68M | 215.09K | 254.61K | 488.79K | 1.11M | 0 | 406.42K | 379.96K | 208.98K | 101.12K |
| Deferred income tax benefit | 6.68M | 215.09K | 254.61K | 488.79K | 1.11M | 0 | 406.42K | 379.96K | 208.98K | 101.12K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 144.14K | -140.62K | -23.51K | 98.17K | 245.42K | -267.98K | 74.47K | -196.23K | 158.76K | -124.38K |
Inventories | 259.58K | -180.64K | -554.78K | 24.94K | 78.81K | -56.10K | -111.97K | 133.08K | -187.82K | -113.87K |
Accounts payable | 0 | 109.31K | -226.77K | -43.81K | 156.90K | 69.59K | 182.01K | -534.14K | -94.39K | -66.99K |
Cash generated by operating activities | -3.18M | -4.47M | -4.86M | -4.88M | -6.32M | -5.69M | -3.90M | -3.80M | -3.81M | -3.21M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -7.49K | -20.75K | -122.94K | -1.66K | -23.37K | 0 | -171.82K | -7.20K | -9.41K | -7.13K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -7.49K | -20.75K | -122.94K | -796.66K | -23.37K | 0 | -171.82K | -7.20K | -9.41K | -7.13K |
Financing activities | ||||||||||
Common Stock Issued | 231.11K | 25K | 7.26B | 255.25M | 3.27B | 50.10M | 19.5K | 530.96K | 399.54K | 149.16K |
Payments for dividends | 0 | -386.3M | 0 | 0 | -205.1M | 0 | -61 | 0 | -23.19K | 0 |
Repurchases of common stock | 0 | 0 | -7.08B | 44.45M | -3.06B | -49.66M | 600K | 63.90K | 6.44M | 82.91K |
Repayments of term debt | 2.71M | 3.46M | -3.70M | -4.35M | 3.00M | -5.82M | 3.91M | -1.07M | 3.56M | -719.79K |
Cash used in financing activities | 3.27M | 4.37M | 5.10M | 5.66M | 6.27M | 5.71M | 4.01M | 3.83M | 3.47M | 3.66M |
Net Change In Cash | 77.41K | -128.44K | 113.77K | -11.08K | -73.49K | 22.08K | -57.33K | 21.58K | -357.16K | 442.53K |
Cash at end of period | 81.27K | 3.86K | 132.31K | 18.54K | 29.62K | 103.11K | 81.03K | 138.36K | 116.78K | 473.94K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |